• Molecular NameAmlodipine
  • SynonymTrospiumAmlodipine Benzenesulfonate; Amlodipine Besilate; Amlodipine Besylate; Amlodipine Free Base; Amlodipino [Spanish]; Amlodipinum [Latin]
  • Weight408.882
  • Drugbank_IDDB00381
  • ACS_NO88150-42-9
  • Show 2D model
  • LogP (experiment)3.17
  • LogP (predicted, AB/LogP v2.0)3.09
  • pka8.6
  • LogD (pH=7, predicted)0.8
  • Solubility (experiment)0.0753 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-3.13
  • LogSw (predicted, AB/LogsW2.0)0.01
  • Sw (mg/ml) (predicted, ACD/Labs)0.01
  • No.of HBond Donors3
  • No.of HBond Acceptors7
  • No.of Rotatable Bonds10
  • TPSA99.88
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA long-acting calcium channel blocker (dihydropyridine class) used as an anti-hypertensive and in the treatment of angina.
  • Absorption_value100.0
  • Absorption (description)Amlodipine is slowly and almost completely absorbed after oral administration; peak plasma concentrations occur after 6 to 12 h. Absorption is not affected by food.
  • Caco_2N/A
  • Bioavailability74.0
  • Protein binding93.0
  • Volume of distribution (VD)16 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmIt undergoes minimal presystemic metabolism; bioavailability is about 60 to 65% and it undergoes extensive but slow metabolism in the liver. Metabolites lack significant pharmacological activity.
  • Half life39 h
  • ExcretionExcreted predominantly in urine (about 60% of a dose); less than 10% of a dose is excreted as the unchanged drug. About 20 to 25% of a dose is eliminated via bile. It is not removed by haemodialysis.
  • Urinary Excretion10
  • Clerance5.9 ml/min/kg.
  • ToxicityGross overdosage could result in excessive peripheral vasodilatation and possibly reflex tachycardia. Marked and probably prolonged systemic hypotension up to an including shock with fatal outcome have been reported.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A